Slocum, Gordon & Co »

Novartis shares owned by Slocum, Gordon & Co

Quarter-by-quarter ownership of Novartis (NVS) shares owned by Slocum, Gordon & Co from 13F filings

Historical chart of Slocum, Gordon & Co investment in Novartis

Tip: Access up to 7 years of quarterly data

All positions including Novartis held by Slocum, Gordon & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Novartis by Slocum, Gordon & Co

Quarter filed Position value Share count Share price at filing
2024-03-31 $7.1k 73 96.73
2023-12-31 $7.4k 73 100.96

More positions owned by Slocum, Gordon & Co

Merck & Co (MRK)
Procter & Gamble Company (PG)
Exxon Mobil Corporation (XOM)
Johnson & Johnson (JNJ)
Abbvie (ABBV)
Nextera Energy (NEE)
American Electric Power Company (AEP)
Verizon Communications (VZ)
Kenvue (KVUE)
PPL Corporation (PPL)
Pfizer (PFE)
Devon Energy Corporation (DVN)
JPMorgan Chase & Co. (JPM)
Duke Energy Corp Com New (DUK)
Weyerhaeuser Co Mtn Be Com New (WY)

View all positions for Slocum, Gordon & Co

Top funds holding Novartis

Dodge & Cox
PRIMECAP Management Company
Dimensional Fund Advisors
Franklin Resources
Bank of America Corporation
Wellington Management Company
Goldman Sachs Group
Henderson Group
Principal Financial Group
Mondrian Investment Partners
Wells Fargo & Company
UBS Group
Cullen Capital Management
Fisher Investments
Scharf Investments

View all funds holding Novartis